WTW

A New York court has ruled that the names of two clients who are friends with a broker who has left Willis Re to join rivals TigerRisk can be published.

Further details of the proposed remedies to the European Commission are revealed.

The executive has been named head of its healthcare division.

The move follows Willis’ explorations of sales of Willis Re and European units.

The Competition and Consumer Commission of Singapore launches a public consultation over the proposed merger deal.

The broker says clients in the sector are using local investment as a key tool to mitigate supply chain risk.

This week, we revealed that Aon/Willis Towers Watson are looking to separately divest a block of Willis' European businesses and Willis Re, as they work to get their mega merger approved by regulators in the face of competition concerns.

It is understood that the ~$300mn fac business will be packaged along with the treaty unit.

The largest of the businesses, Gras Savoye, has been seen as one of the jewels in the crown at Willis.

Both Bart and Matte join as directors, with the former arriving from Milliman and the latter joining from Promutuel Insurance.

The potential disposal may help to alleviate competition concerns within the French market.

The Aon president said insureds will begin to “test” carriers and brokers on price.